102 related articles for article (PubMed ID: 11196836)
21. Virtually complete control of simple and face diastereoselectivity in the Michael addition reactions between achiral equivalents of a nucleophilic glycine and (S)- or (R)-3-(E-enoyl)-4-phenyl-1,3-oxazolidin-2-ones: practical method for preparation of beta-substituted pyroglutamic acids and prolines.
Soloshonok VA; Ueki H; Tiwari R; Cai C; Hruby VJ
J Org Chem; 2004 Jul; 69(15):4984-90. PubMed ID: 15255725
[TBL] [Abstract][Full Text] [Related]
22. Protection by pyroglutamic acid and some of its newly synthesized derivatives against glutamate-induced seizures in mice.
Beani L; Bianchi C; Baraldi PG; Manfredini S; Pollini GP
Arzneimittelforschung; 1990 Nov; 40(11):1187-91. PubMed ID: 1982209
[TBL] [Abstract][Full Text] [Related]
23. NMR assignment of a PDZ domain in complex with a HPV51 E6 derived N-terminally pyroglutamic acid modified peptide.
Mischo A; Ohlenschläger O; Ramachandran R; Görlach M
Biomol NMR Assign; 2013 Apr; 7(1):47-9. PubMed ID: 22392342
[TBL] [Abstract][Full Text] [Related]
24. Synthesis of [(11)C]GSK1482160 as a new PET agent for targeting P2X(7) receptor.
Gao M; Wang M; Green MA; Hutchins GD; Zheng QH
Bioorg Med Chem Lett; 2015 May; 25(9):1965-70. PubMed ID: 25819093
[TBL] [Abstract][Full Text] [Related]
25. Synthesis and characterization of water-soluble silver(I) complexes with L-histidine (H2his) and (S)-(-)-2-pyrrolidone-5-carboxylic acid (H2pyrrld) showing a wide spectrum of effective antibacterial and antifungal activities. Crystal structures of chiral helical polymers [Ag(Hhis)]n and ([Ag(Hpyrrld)]2)n in the solid state.
Nomiya K; Takahashi S; Noguchi R; Nemoto S; Takayama T; Oda M
Inorg Chem; 2000 Jul; 39(15):3301-11. PubMed ID: 11196868
[TBL] [Abstract][Full Text] [Related]
26. Deblocking of proteins containing N-terminal pyroglutamic acid.
Mozdzanowski J
Methods Mol Biol; 2003; 211():365-9. PubMed ID: 12489444
[No Abstract] [Full Text] [Related]
27. Discovery and structure-activity relationships of a series of pyroglutamic acid amide antagonists of the P2X7 receptor.
Abdi MH; Beswick PJ; Billinton A; Chambers LJ; Charlton A; Collins SD; Collis KL; Dean DK; Fonfria E; Gleave RJ; Lejeune CL; Livermore DG; Medhurst SJ; Michel AD; Moses AP; Page L; Patel S; Roman SA; Senger S; Slingsby B; Steadman JG; Stevens AJ; Walter DS
Bioorg Med Chem Lett; 2010 Sep; 20(17):5080-4. PubMed ID: 20673717
[TBL] [Abstract][Full Text] [Related]
28. Isotopic variants of light and heavy L-pyroglutamic acid succinimidyl esters as the derivatization reagents for DL-amino acid chiral metabolomics identification by liquid chromatography and electrospray ionization mass spectrometry.
Mochizuki T; Todoroki K; Inoue K; Min JZ; Toyo'oka T
Anal Chim Acta; 2014 Feb; 811():51-9. PubMed ID: 24456594
[TBL] [Abstract][Full Text] [Related]
29. Tunable thermoresponsive pyrrolidone-based polymers from pyroglutamic acid, a bio-derived resource.
Bhat R; Pietrangelo A
Macromol Rapid Commun; 2013 Mar; 34(5):447-51. PubMed ID: 23319232
[TBL] [Abstract][Full Text] [Related]
30. Synthesis, physical properties, toxicological studies and bioavailability of L-pyroglutamic and L-glutamic acid esters of paracetamol as potentially useful prodrugs.
Bousquet E; Marrazzo A; Puglisi G; Spadaro A; Tirendi S
J Pharm Pharmacol; 1996 May; 48(5):479-85. PubMed ID: 8799871
[TBL] [Abstract][Full Text] [Related]
31. N-9-fluorenylmethoxycarbonylpyroglutamate. Preparation of the acid, chloride and succinimidyl ester.
Benoiton NL; Chen FM
Int J Pept Protein Res; 1994 Apr; 43(4):321-4. PubMed ID: 8045676
[TBL] [Abstract][Full Text] [Related]
32. NH-type of chiral Ni(II) complexes of glycine Schiff base: design, structural evaluation, reactivity and synthetic applications.
Bergagnini M; Fukushi K; Han J; Shibata N; Roussel C; Ellis TK; Aceña JL; Soloshonok VA
Org Biomol Chem; 2014 Feb; 12(8):1278-91. PubMed ID: 24424805
[TBL] [Abstract][Full Text] [Related]
33. A unified strategy targeting the thiodiketopiperazine mycotoxins exserohilone, gliotoxin, the epicoccins, the epicorazines, rostratin A and aranotin.
Gross U; Nieger M; Bräse S
Chemistry; 2010 Oct; 16(38):11624-31. PubMed ID: 20809554
[TBL] [Abstract][Full Text] [Related]
34. Perpetually self-propelling chiral single crystals.
Panda MK; Runčevski T; Husain A; Dinnebier RE; Naumov P
J Am Chem Soc; 2015 Feb; 137(5):1895-902. PubMed ID: 25581716
[TBL] [Abstract][Full Text] [Related]
35. Complete crystal structure of monocyte chemotactic protein-2, a CC chemokine that interacts with multiple receptors.
Blaszczyk J; Coillie EV; Proost P; Damme JV; Opdenakker G; Bujacz GD; Wang JM; Ji X
Biochemistry; 2000 Nov; 39(46):14075-81. PubMed ID: 11087354
[TBL] [Abstract][Full Text] [Related]
36. Novel methodologies for the synthesis of functionalized pyroglutamates.
Tekkam S; Alam MA; Jonnalagadda SC; Mereddy VR
Chem Commun (Camb); 2011 Mar; 47(11):3219-21. PubMed ID: 21318205
[TBL] [Abstract][Full Text] [Related]
37. Efficient asymmetric synthesis of novel 4-substituted and configurationally stable analogues of thalidomide.
Yamada T; Okada T; Sakaguchi K; Ohfune Y; Ueki H; Soloshonok VA
Org Lett; 2006 Nov; 8(24):5625-8. PubMed ID: 17107088
[TBL] [Abstract][Full Text] [Related]
38. Mass spectrometric identification of pyroglutamic acid in peptides following selective hydrolysis.
Mandal AK; Balaram P
Anal Biochem; 2007 Nov; 370(1):118-20. PubMed ID: 17662685
[No Abstract] [Full Text] [Related]
39. From N-triisopropylsilylpyrrole to an optically active C-4 substituted pyroglutamic acid: total synthesis of penmacric acid.
Berini C; Pelloux-Léon N; Minassian F; Denis JN
Org Biomol Chem; 2009 Nov; 7(21):4512-6. PubMed ID: 19830303
[TBL] [Abstract][Full Text] [Related]
40. Supramolecular approach by using Jahn-Teller sites to construct a {Mn13}-based coordination polymer and modify its magnetic properties.
Zhang L; Clérac R; Onet CI; Venkatesan M; Heijboer P; Schmitt W
Chemistry; 2012 Oct; 18(44):13984-8. PubMed ID: 22997005
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
